Want to join the conversation?
$HCP 2Q15 PR: HCP reported total revenues of $607.53MM vs. $536.12MM in 2Q14. Net income was $164.52MM vs. $218.40MM in 2Q14. Diluted EPS was $0.36 vs. $0.48 in 2Q14. Net operating income was $434.79MM vs. $439.87MM in 2Q14. On July 30, 2015, HCP's BoD declared a quarterly cash dividend of $0.565 per common share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?